Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Obstructive Sleep Apnea on Severity and Prognosis of Patients With IgA Nephropathy

NCT06393036 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT06393036
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06393036 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Obstructive Sleep Apnea on Severity and Prognosis of Patients With IgA Nephropathy
Lead sponsor
Peking University First Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 15, 2024
Completion date
June 30, 2026
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

iga nephropathy, obstructive sleep apnea